Nanjing YOKO Pharmaceutical Co., Ltd. – FDA Inspection, Aug 7, 2026

Record Details

This FDA Inspection record concerns Nanjing YOKO Pharmaceutical Co., Ltd., with an inspection on August 7, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Nanjing YOKO Pharmaceutical Co., Ltd.
Inspection Date: August 7, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Adetutu M. Gidado (Issuing Officer)

View Company Profile

ID · 5ebebf90-3705-4f13-b08f-1ede48d8eb30

Inspection Facts

Inspection number: 1335300
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nanjing YOKO Pharmaceutical Co., Ltd.

FDA Inspection

Nanjing YOKO Pharmaceutical Co., Ltd.August 7, 2026

Nanjing YOKO Pharmaceutical Co., Ltd. – FDA Inspection, Aug 7, 2026

Record Details

This FDA Inspection record concerns Nanjing YOKO Pharmaceutical Co., Ltd., with an inspection on August 7, 2026, issued by the Office of Inspections and Investigations, covering human drugs.